We’re pleased to announce that our CEO Chris Penfold will be presenting at the ‘Future in Design’ Learnshop. (Easyfairs, NEC, UK)

Chris’s presentation entitled ‘Web 2.0 & Web Squared – implications 4 packaging design now & future’ will take place at 3pm on Wednesday 24^th and is not to be missed. 

In it Chris will be talking about the growing effect, implications and opportunities of the internet on the packaging design process and on ways of working.  He will be looking at the convergence of Web & technology and the effect on consumer and patient interaction and personalisation, with some great examples of emerging and leading-edge packaging design.

If you’re at easyFairs why not pop along and have a listen.  You can register FREE for easyFairs NEC (avoiding a £20 entrance fee) by following this link and becoming a Design Cognition visitor.

You can find out more about all the Learnshops here on the main easyFairs web site.

Design Cognition are offering a limited number of FREE product and packaging advisory sessions.  Are you worried about the non-compliance of any of your products?  Do you know what regulations your products need to comply to? – Why not book yourself one of these limited sessions and come for a chat?

 If you are attending easyFairs Packaging Innovations show at the NEC (UK 24-25 Feb) then why not take advantage of this fantastic FREE offer?  To book one of the limited 15 minute sessions simply email packagingsurgery@designcognition.com

 Places are limited though, so if you aren’t quick enough to book one, why not visit us on STAND 582 – right by the main entrance – to leave us your details and arrange a follow-up chat after the show.

If you’ve not already registered for the show why not do it now by following this link and becoming a Design Cognition visitor.

It seems that despite the economic downturn and environmental concerns regarding it’s packaging and transportation the global market for bottled water is still growing.  How much longer can this continue though and what alternatives could we offer? (Jane)

Global bottled water sales increased in 2009 as growth in China compensated for declines in Western Europe and North America, according to Canadean. According to its recently published Global Bottled Water Report, the worldwide market grew 2 per cent despite the combined impact of the recession and growing environmental concerns.

http://bit.ly/7VXbMw

Interesting move from Nestle, who will be next to follow?  There is definitely a market out there, and as the average age of the population rises and people live longer it’s an area of the market that is likely to grow in size. I hope they’ve got the packaging right though – easy to open closure and legible text will be a must! (Jane)

Nestlé has launched a 200mL nutrient drink in Switzerland targeting the malnourished elderly – a segment of the population it says is deficient in key nutrients such as vitamin D, calcium and protein.

via Nestlé target elderly with high-dose drink.

Well, the anti-aging colour foundations have already proved very popular, as have the anti-aging lipsticks, so I suppose it’s only natural that the eyes should be the next target. (Jane)

The cosmetic-skincare hybrid category is, according to Nica Lewis, director of beauty innovation at market researcher Mintel, a new class of products in the prestige beauty sector that combine color cosmetics with skincare functions.

via Innovation leads to anti-aging color cosmetics for eyes.

Interesting article.  I believe the biggest majority of the packaging will be manufactured in the country, but if you have the technology/machinery for sale it might be worth you considering India as your next target market.  Their upgrades and increased sophistication will have to come from somewhere.  (Jane)

Food packaging in India will undergo huge changes in the next five years as companies increasingly use it as an important vehicle for product differentiation, said a report from Datamonitor.

via India set for food packaging revolution.

“Innovation is the key to our industry breaking out of recession, says Keith Barnes, chairman of IoP: The Packaging Society”, a subject that is ‘dear to my heart’. There is much rhetoric spouted from many quarters (not just the packaging industry for that matter) who only pay ‘lip service’ to innovation. In these recessionary times it is sad to see that true ‘innovation’ either ‘thrown out of the window’  totally or is put ‘on the back burner’ in anticipation of ’sunnier days’. Luckily some companies have had the foresight to see beyond the present ‘mire’ and are using innovation (in product developments, processes and the way they think) to position themselves and their brands in such a way that they will be ‘ahead of the pack’ when the economic climate has improved. Indeed, at Design Cognition, we are lucky enough to be working with some of these forward-thinking companies and I ‘tip my hat’ to them. If you’d like further information on particular areas of innovation and how Design Cognition can help, you can find out more and contact us here: Design Cognition Innovation

Chris Penfold

In his article, Keith says “Despite being the world’s third largest industry, packaging is still sadly perceived by the vast majority of people as  cardboard boxes and wrapping paper. As chairman of The Packaging Society, and with the industry’s support, I am determined to change this image. With the best will in the world, this will not happen overnight. What’s more, the task is going to be made increasingly difficult by so many companies and individuals focusing on their survival in the current economic climate.”

Sourced from Packaging News 6th January 2010, Keith Barnes

You can read the full article here: The enigma of  packaging innovation

PACKAGING AND LABELING HELP FIGHT DRUG COUNTERFEITS

In the U.S.Food and Drug Administration’s ongoing battle against counterfeit drug products, the latest FDA guidance is aimed directly at packaging techniques.In a July guidance document to industry, the FDA set forth some suggestions for incorporating so called “physical-chemical identifiers” PCIDs into solid oral dosageform drug products and paid particular attention to those that might migrate from packaging or container labeling.The FDA defines a PCID as a product with some unique physical and or chemical characteristic that is added to the dosage form of a drug product and which “makes it possible to detect and authenticate legitimate dosage forms and identify counterfeits.”These so-called PCIDs can include inks, pigments, flavors, or molecular taggants, says the FDA. And the agency expects that many of them would be made of existing substances used in food additives, colorants, or drug products’ excipients.The FDA’s guidance document, entitled “Incorporation of Physical-Chemical Identifiers Into Solid Oral Dosage Form Drug Products For Anticounterfeiting,” is primarily concerned with helping drug makers and applicants for new drug approvals incorporate relevant information about their PCIDs into new drug applications, supplemental applications, and annual reports submitted to the FDA.The guidance does not attempt to address radio frequency identification RFID.Counterfeits have tended to be a bigger problem overseas than in the U.S., though it is a concern here, and not just when drugs are imported. The FDA has always recognized the importance of packaging technologies as potential solutions, including but not limited to RFID.Confirming the authenticity of any individual package of drugs, or, when possible, even an individual dosage, is the essence of thwarting counterfeits. In the complex distribution network through which drug products travel, opportunities abound to introduce counterfeit product into the mix.Counterfeits can come in many forms. For example, they might be products that are just imitations, and literally lack the right ingredients, or are out-of-date versions of the real thing, or are otherwise diverted from the ordinary authorized distribution pathways. It is a recognized phenomenon that authentic and appropriate products are often mixed with inauthentic counterfeits, meaning the confirmation of authenticity often involves measures going to the individual dosage level. Hence, ideas like PCIDs.As for PCIDs that are added to packaging or labeling of drug products in solid oral dosage form, the FDA makes specific recommendations on how to evaluate toxicological concerns and offers guidance on when and how to report or request approval of the addition of a PCID. The agency points out that, as expected, its “toxicological concerns are mitigated if the added substances is a permitted direct or indirect food additive,” or listed in the FDA’s Inactive Ingredient Guide.If the substance you want to use as a PCID in packaging is not the subject of known toxicological information, the packager should, says the FDA, determine that there won’t be migration of the substance into the products. If some interaction of the PCID with the product is expected, and toxicological concerns may result, the FDA suggests packagers contact the agency to discuss the issues. If the toxicology of the substance hasn’t been established, and the potential for its migration exists, the FDA says the drug product with that PCID in it would require a prior approval supplement before marketing.When it comes to PCIDs in solid oral dosage-form products, the FDA is hoping to help industry follow one of its key pieces of advice: Use a multifaceted approach to counterfeiting in order to stay at least one step ahead of counterfeiters.

via Healthcare Packaging – December 2009 : ANTI-COUNTERFEITING: WHEN PACKAGING AND LABELING HELP FIGHT DRUG COUNTERFEITS.

Drug approvals from the Food and Drug Administration were flat last year compared with 2008 and warnings fell, even as the agency’s new leadership struck a tougher stance on safety.

The FDA approved 26 first-of-a-kind prescription drugs last year, up slightly from 25 in 2008, according to figures from Washington Analysis, an investment research group. New drugs cleared in 2009 included Novartis’ kidney cancer drug Afinitor and Bausch and Lomb’s pink eye medicine Besivance.

Chris Penfold – there are a number of reasons froi this trend, one of them being a reduced number odf applications – so we can’t read too much in to this report.

Sourced from Pharmaceutical & Medical News, 6th January 2010 – Washington, USA

Read the full article at: Pharmaceutical & Medical Packaging News

The normal packaging development  process would involve firstly developing a pack to fit the product in an optimum manner. Then any legally required text would be positioned (including any required symbols, such as recycling logos). Finally the marketing requirements would be implemented, in terms of claims, branding etc. More often than not, there is then a need to go back to product marketers to get them to reduce their marketing copy on the packs, because it simply won’t fit……..and the situation is getting worse!

Other options that can help tackle this problem are:

A, reducing the font size – but this can have implications on readability, print process constraints and there is often a legal minimum size which needs to be adhered to.

B, Using paginated label leaflet formats – where, on occasions, we have developed up to a 10-page concertina style leaflets. However, these multi-layered add-ons can add a huge on-cost onto the price of a pack – for which marketers don’t always want to pay.

C, Printing on the inside of pack (e.g. cartons) – but not visible until a pack is opened. So one can’t do this with certain text which needs to be visible at time of purchase

D, Finally, if all else fails, considering increasing the overall size of the packaging.

An example of a multi-page label solution

This latter route is sometimes unavoidable, especially with pharmaceutical packs, where the packs are very small, and even after taking measures such as reducing the bar codes from 13 digit to 8 digit, there is simply not enough room to display the mandatory legal minimum required text (let alone any marketing text).

Furthermore, it is now the law for any new medicines to incorporate Braille on the packaging (it will be a requirement for all existing medicines by October 2010). This will have to detail the product name, the strength [of the medication] and the dose form – yet another constraint to bear in mind. New products also have to conform with the readability guidelines which are in place to ensure that the packs can be read clearly and understood by the patient/consumer).

It’s worth remembering that it’s not just the basic information that one has to put on the pack. Very this has to be repeated it in a number of  different languages. It’s not unusual for a European product to have a need for 12 languages. And then there might be a need to repeat ‘country of origin’ for every language, and could require five countries needing to be listed (for a range of ingredients). The result could be a situation where  all one has room to display is a list of ingredients  & addresses, and any wish for aesthetic beauty just ‘goes out of the window’.

At Design Cognition, we review the whole space to find an ideal design that looks most aesthetically appealing and hopefully doesn’t look too cluttered – but it’s not always easy!

Incorporating logos of different colours, or trying to mix varying colours of text with backgrounds, can add its own issues and problems. Sometimes ‘house colours’ do not lend themselves to readability, White text on a pastel or black background for instance, can be even harder to read, so we may need to redesign [the pack graphics], using the principles and processes detailed above.

Overall our job is to develop a pack that is fit for purpose and not over-packaged. Things are becoming increasingly challenging but, so far our use of creativity and lateral thinking has provided a suitable solution.

Moving forwards technology could aid some of the issues raised above. Nowadays, certain consumer/marketing information can be shown ‘on-line’, cutting down the need to put it all on-pack – maybe just a web address for further information. There have also been great leaps forward in microchip technology which will enable ‘talking packs’, ‘moving pictures’ and a whole new interactive consumer experience – taking packaging to a new level. These are all areas in which Design Cognition has a strong interest and is working with a number of suppliers to develop cost-effective solutions.

If you’d like more information on these areas, sign up for further information HERE

Chris Penfold